A comparative analysis of bilateral subcapsular orchidectomy and bilateral total orchidectomy in evaluating castration timeline in prostate cancer subjects

Bilateral subcapsular orchidectomy vs bilateral total orchidectomy: assessment of the castration timeline in patients with prostate cancer

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

PACTR

Registry ID

PACTR202311880225067

Enrollment

Registered

2023-11-21

Start date

2023-12-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Surgery Urological and Genital Diseases

Interventions

BILATERAL SUBCAPSULAR GROUP or BSO GROUP

BILATERAL TOTAL ORCHIDECTOMY GROUP OR BTO GROUP

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Patient with clinical, laboratory and radiologic features and histologically diagnosed prostate cancer

Exclusion criteria

Exclusion criteria: Patients with no histopathologic confirmation of prostate cancer. Patients with prostate cancer who are on any form of prostate cancer androgen ablation therapy (GnRH agonist, stilboestrol, or antiandrogen). Patients with chronic liver disease. Any patient with clinical ultrasonic or radiologic features of tumour other than prostate cancer

Design outcomes

Primary

Measure	Time frame
To compare the effectiveness of the two techniques in inducing castration	—

Secondary

Measure	Time frame
To assess the rate of fall of serum testosterone in the two study groups;To assess the hemodynamic status of the subjects at the immediate post operative state	—

Countries

Nigeria

Contacts

Public ContactPEACE ASIKA

SCIENTIFIC OFICER

peaceka92@gmail.com+2348134632746

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026